Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

4.23
Delayed Data
As of Apr 29
 -0.12 / -2.76%
Today’s Change
3.68
Today|||52-Week Range
20.43
-45.35%
Year-to-Date
No recent news for Nivalis Therapeutics Inc.

Today’s Trading

Previous close4.35
Today’s open4.38
Day’s range4.20 - 4.39
Volume14,897
Average volume (3 months)70,609
Market cap$65.4M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-268.18%
Earnings growth (this year)+19.20%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
VCELVericel Corp-0.16-5.26%
OREXOrexigen Therapeutic...-0.02-4.20%
REPHRecro Pharma Inc-0.04-0.58%
RNNRexahn Pharmaceutica...-0.00-1.15%
Data as of 4:02pm ET, 04/29/2016

Financials

Next reporting dateJune 1, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$0.00
Annual profit (last year)-$22.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs